CASI Pharmaceuticals (CASI) Reports Q1 Loss of $0.06/Share

CASI Pharmaceuticals (NASDAQ: CASI) reported Q1 EPS of ($0.06), versus ($0.05) reported last year. Revenue for the quarter came in at $23.7 thousand, versus $0 reported last year.

For earnings history and earnings-related data on CASI Pharmaceuticals (CASI) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• KeyBanc Reiterates Overweight Rating on Brinker Int'l (EAT)
• JPMorgan Downgrades Shanghai Chicmax Cosmetic (2145:HK) to Neutral